Zurcher Kantonalbank (Zurich Cantonalbank) Chinook Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $30.1 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
BUY
$18.66 - $38.58 $28,493 - $58,911
1,527 Added 26.14%
7,368 $283,000
Q1 2023

May 08, 2023
SELL
$21.53 - $26.8 $10,420 - $12,971
-484 Reduced 7.65%
5,841 $135,000
Q4 2022

Feb 01, 2023
SELL
$18.63 - $27.35 $42,066 - $61,756
-2,258 Reduced 26.31%
6,325 $165,000
Q3 2022

Nov 09, 2022
BUY
$17.51 - $23.37 $119,698 - $159,757
6,836 Added 391.3%
8,583 $169,000
Q2 2022

Aug 09, 2022
SELL
$12.59 - $18.8 $2,215 - $3,308
-176 Reduced 9.15%
1,747 $31,000
Q1 2022

Apr 21, 2022
BUY
$12.02 - $16.69 $23,114 - $32,094
1,923 New
1,923 $31,000

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email